0690.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 11:08):

Stats
Dzisiejszy wolumen	3.39M
Średni wolumen	4.72M
Kapitalizacja rynkowa	486.21M
EPS	HKD0 ( 2023-08-28 )
Następna data zysków	( HKD0 ) 2024-05-16
Last Dividend	HKD0.00224 ( 2007-08-22 )
Next Dividend	HKD0 ( N/A )
P/E	8.00
ATR14	HKD0.00200 (2.41%)

Uni-Bio Science Group Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Uni-Bio Science Group Finanse

Annual	2023
Przychody:	HKD484.72M
Zysk brutto:	HKD390.46M (80.55 %)
EPS:	HKD0.0111

FY	2023
Przychody:	HKD484.72M
Zysk brutto:	HKD390.46M (80.55 %)
EPS:	HKD0.0111

FY	2022
Przychody:	HKD440.32M
Zysk brutto:	HKD334.88M (76.06 %)
EPS:	HKD0.00600

FY	2021
Przychody:	HKD353.41M
Zysk brutto:	HKD277.01M (78.38 %)
EPS:	HKD-0.00306

Financial Reports:

No articles found.

Uni-Bio Science Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Uni-Bio Science Group Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.31 - Potential for dividend initiation, but uncertain (13.81%)

Information

First Dividend	HKD0.00224	2007-08-22
Last Dividend	HKD0.00224	2007-08-22
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	HKD0.00224	--
Avg. Dividend % Per Year	0.00%	--
Score	2.37	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.31
Div. Directional Score	7.86	--

Next Divdend (Est)
(2024-05-06)

HKD0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

2.37

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3958.HK	Ex Dividend Junior	2023-05-23	Annually	0.00%
1773.HK	Ex Dividend Junior	2023-06-15	Annually	0.00%
0816.HK	No Dividend Player	2023-06-12	Insufficient data to determine frequency	0.00%
2359.HK	Ex Dividend Knight	2023-06-05	Annually	0.00%
1336.HK	Ex Dividend Junior	2023-07-06	Annually	0.00%
0386.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
6668.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
1890.HK	Ex Dividend Knight	2023-08-04	Annually	0.00%
0916.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
0038.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.146	1.500	7.08	10.00	[0 - 0.5]
returnOnAssetsTTM	0.259	1.200	1.356	1.628	[0 - 0.3]
returnOnEquityTTM	0.441	1.500	6.21	9.31	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.07	0.800	4.63	3.70	[1 - 3]
quickRatioTTM	1.870	0.800	3.71	2.96	[0.8 - 2.5]
cashRatioTTM	1.126	1.500	4.86	7.28	[0.2 - 2]
debtRatioTTM	0.112	-1.500	8.14	-10.00	[0 - 0.6]
interestCoverageTTM	139.25	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.0234	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0140	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.178	-1.500	9.29	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.807	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.150	1.000	9.00	9.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.24	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.773	0.800	1.511	1.209	[0.5 - 2]
Total Score				11.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	4.79	1.000	9.62	0	[1 - 100]
returnOnEquityTTM	0.441	2.50	7.56	9.31	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0140	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0234	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.110	1.500	-2.60	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.205	1.000	7.38	0	[0.1 - 0.5]
Total Score				4.31

Uni-Bio Science Group

Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Bokangtai, a mitiglinide tablet for the treatment of Type 2 diabetes, as well as Boshutai, an oral anti-diabetic drug targeting patients with pre-diabetes condition. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agonist, a non-insulin treatment candidate for the treatment of Type 2 diabetes. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong.